isomethyleugenol has been researched along with Cytomegalic Inclusion Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, FM; Feng, Q; He, F; Hui, J; Li, Z; Liu, YM; Qu, YY; Tang, N; Wang, LM; Zhong, H | 1 |
| Reeves, MB | 1 |
1 review(s) available for isomethyleugenol and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Chromatin-mediated regulation of cytomegalovirus gene expression.
Topics: Acetylation; Chromatin; Cytomegalovirus; Cytomegalovirus Infections; Gene Expression Regulation, Viral; Genes, Immediate-Early; Histones; Humans; Methylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Trans-Activators | 2011 |
1 other study(ies) available for isomethyleugenol and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Pressure; Case-Control Studies; China; Cytomegalovirus; Cytomegalovirus Infections; Deoxyguanosine; Essential Hypertension; Ethnicity; Female; Humans; Male; Methylation; Middle Aged; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Progesterone Reductase; Renin; Tumor Necrosis Factor-alpha | 2018 |